homeBiocon News
Biocon NEWS
business | Apr 17, 2024 9:12 PM ISTBiocon partners Biomm to commercialise diabetes drug in Brazil
- market | Mar 28, 2024 8:01 AM IST
Biocon becomes the first generics company to get a diabetes drug approval in the UK
business | Mar 15, 2024 5:48 PM ISTBiocon Biologics CEO terms Eris Lifesciences deal as enabling, not restricting
market | Mar 14, 2024 3:19 PM ISTBiocon Biologics signs 10-year supply pact with Eris Life for ₹1,242 crore
healthcare | Mar 4, 2024 9:46 AM ISTBiocon Biologics gets Canada market entry date for ophthalmic drug Yesafili
- business | Feb 23, 2024 5:18 PM IST
Biocon gets over ₹3 crore penalty over GST related issues
- market | Feb 9, 2024 10:31 AM IST
Biocon arm gets complete response letter from USFDA for Bevacizumab biosimilar licence application
photos | Feb 9, 2024 12:09 AM ISTStocks to Watch: LIC, Hero Motocorp, Biocon, Grasim Industries, Torrent Power, RVNL and more
earnings | Feb 8, 2024 8:53 PM ISTBiocon bounces back to black, reports ₹660 crore net profit, revenue up 34%
earnings | Jan 25, 2024 3:35 PM ISTSyngene Q3 results: Biocon unit cuts FY24 revenue growth guidance
- healthcare | Dec 22, 2023 5:36 PM IST
Biocon Biologics, Sandoz ink deal to market immune disorder injection adalimumab in Japan
- business | Dec 19, 2023 9:23 AM IST
Biocon chief sees generics business firing up next year
healthcare | Dec 18, 2023 5:07 PM ISTBiocon Biologics takes charge of Viatris' biosimilars across 120 countries
photos | Dec 14, 2023 7:08 AM ISTStocks to Watch: SBI, Biocon, JSW Energy, UltraTech Cement, IndiGo, Fusion Micro Finance and more
- healthcare | Dec 13, 2023 6:30 PM IST
Targeted cancer therapy player Bicara Therapeutics raises $165 mn in Series C financing